Halozyme Therapeutics (NasdaqGS:HALO) Earnings Call Presentation
Halozyme to Acquire Elektrofi Investor Conference Call Non-GAAP Financial Measures: NASDAQ: HALO October 1, 2025 1 Forward Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance and growth rates (including the Company's 2025 financial guidance and the assumptions used in deriving such guidance) including expectations for ...